Other Areas of Therapeutic Expertise

Navigating the challenges of novel therapeutic development is complex, apply our broad experience knowledge base 

Veristat has partnered with clients to bring drugs and biologics to market in nearly every therapy area. While the majority of our ongoing studies are for therapies to treat Cancers, Rare Diseases, Neurological Disorders, Cardiovascular Disease, and Infectious Diseases, our company and experts bring a vast array of therapeutic expertise. We have a diverse portfolio of experience running hundreds of studies outside of our core therapy areas as well.

Broad Range of Therapeutic Experience

Our teams support amazing, cutting-edge, life-enhancing and life-saving therapies that range from chronic and debilitating autoimmune diseases such as Irritable Bowel Syndrome to pediatric gene therapies for treating genetic disorders to live-saving anti-rejection drugs following kidney transplantation. We have the right expertise and therapeutic understanding and creative know-how to help you design, build, and run your clinical development program in any therapeutic area.


Scientific-Minded Experts Across Novel Therapies

  • Allergy/Immunology 
  • Autoimmune Diseases
  • Dermatology
  • Metabolic Disorders
  • Obstetrics/ Gynecology
  • Ophthalmology
  • Orthopedics
  • Pain Management
  • Pulmonary
  • Taste Assessment
  • Urology/Renal
  • Vascular disease

Learn More with These Resources

Fact Sheet
Regulatory Consulting Fact Sheet

Regulatory planning for your clinical development program starts before and continues after you begin preparing your Investigational New Drug (IND) application. As ...

Fact Sheet
Protocol Specific Feasbility

In order to avoid clinical trial delays, a feasbility study will help you select and predict your best performing sites. Identifying the right KOLs and clinical ...

Case Study
Preparing a New Drug Application (IND)

Veristat has collaborated with biopharmaceutical firms on the preparation of over 50 INDs. Learn how we successfully helped a sponsor finalize their IND in under 6 ...

Request A Proposal